throbber
2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 1 of 25
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF SOUTH CAROLINA
`CHARLESTON DIVISION
`
`Belimed, Inc.
`
`v.
`Jeffrey Bleecker,
`
`Plaintiff,
`
`Defendant.
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`2:22-cv-00891-DCN
`Civil Action No. __________________
`VERIFIED COMPLAINT
`(PRELIMINARY INJUNCTION REQUESTED)
`
`Plaintiff Belimed, Inc. (“Belimed”), by and through its undersigned counsel, hereby
`
`brings the following Verified Complaint for preliminary and permanent injunctive relief,
`
`monetary damages, and other relief against its former employee, defendant Jeffrey Bleecker, for
`
`his violation of his Non-Disclosure, Non-Solicitation, and Non-Competition Agreement (the
`
`“Agreement”) with Belimed. In this case, Defendant Bleecker expressly agreed that because he
`
`was privy to Belimed’s confidential and proprietary trade secret and business information that he
`
`would not work for Belimed’s direct competitor Getinge Corporation (“Getinge”) for one year
`
`following his departure from Belimed. Bleecker left Belimed at the end of 2021 and informed
`
`Belimed that he would be returning to his own general contracting business. Belimed, however,
`
`learned very recently that Bleecker has gone to work in a similar role at Getinge in direct
`
`violation of his agreement not to do exactly that. Bleecker also retained Belimed’s documents –
`
`including a screenshot of an internal presentation on new Belimed technology – upon his
`
`departure from Belimed, creating a clear and imminent threat that Bleecker will share Belimed’s
`
`trade secrets and confidential or otherwise proprietary information in connection with his
`
`position at Getinge. Even putting aside Bleecker’s actual misappropriation of Belimed’s trade
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 2 of 25
`
`secrets, the similarity between his role at Belimed and his role at Getinge will inevitably result in
`
`Bleecker disclosing and using Belimed’s proprietary information to perform his role at Getinge.
`
`Bleecker also takes with him the customer goodwill that he built at Belimed. If Bleecker is
`
`allowed to continue working for Getinge before the expiration of his non-compete period, or if
`
`Belimed’s confidential information is obtained and used by Getinge, Belimed will lose its
`
`competitive advantage over Getinge and the customer goodwill it has invested time and
`
`resources to achieve. Because Belimed faces immediate and irreparable harm as a result,
`
`Belimed brings this civil action and Belimed alleges as follows:
`
`INTRODUCTION
`
`1. Bleecker was employed by Belimed from May 4, 2015 to December 31, 2021. Prior
`
`to his departure from Belimed, Bleecker was a Senior Planning and Design Manager for Belimed
`
`in their West region. In this role, Bleecker was privy to and worked regularly with Belimed’s
`
`trade secrets and confidential information, including pricing structure and strategy, proprietary
`
`tools and software, research and development pipelines and initiatives, and current and potential
`
`customers. Bleecker’s position also gave him access to highly confidential information about
`
`Belimed’s business strategies that would be valuable to any of Belimed’s competitors.
`
`2. Knowing he would be given access to Belimed’s inside confidential information,
`
`Bleecker signed the Agreement at the outset of his employment and as a condition of his at-will
`
`employment. A true and accurate copy of the Agreement is attached hereto as Exhibit A. The
`
`Agreement includes necessary and reasonable restrictive covenants. By signing the Agreement,
`
`Bleecker expressly agreed not to work for two named Belimed competitors, Getinge and Steris
`
`Corporation, for a period of one year following his departure from Belimed. Ex. A, ¶3. Bleecker
`
`also agreed not to disclose any trade secrets or confidential information, id. ¶1, or to solicit any
`
`
`
`- 2 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 3 of 25
`
`employee to leave Belimed, id. ¶2. Bleecker expressly agreed in the Agreement that the
`
`restrictive covenants contained in the Agreement would not prevent him from earning a living,
`
`that the limited restrictions in the Agreement were “reasonable and necessary to protect
`
`[Belimed’s] legitimate business interests” and that any breach of the Agreement would cause
`
`Belimed irreparable harm and that Belimed would be entitled to obtain temporary and permanent
`
`injunctive relief against any breach of the Agreement. Id. ¶¶1(e), 4, 5, 8.
`
`3. Bleecker ended his employment with Belimed on December 31, 2021. Bleecker
`
`represented to Belimed at that time that he was returning to the role of entrepreneur and would
`
`be building his general contractor business, a statement at odds with his downloading of
`
`confidential information prior to his departure and quick transition to Getinge.
`
`4. On or around February 2022, less than three months after his departure from Belimed,
`
`Bleecker began working as a Healthcare Planning and Design Manager for Getinge. See Exhibit
`
`B, Declaration of Ross Polston (“Polston Decl.”), ¶23; Ex. 1. As of the date hereof, Bleecker is
`
`in the process of onboarding at Getinge and most likely has not had the opportunity to fully
`
`disclose the Belimed confidential information he has or make use of Belimed’s goodwill.
`
`5. Bleecker announced in February 2022 via LinkedIn that he will hold a similar
`
`position at Getinge as he did at Belimed. Polston Decl. ¶¶23–25, Ex. 1. As such, Bleecker’s
`
`work for Getinge will necessarily encompass the work he performed for Belimed. At Getinge,
`
`Bleecker will directly employ Belimed’s confidential and proprietary information. He will also
`
`use Belimed’s goodwill and make use of the contacts Belimed introduced him to in the form of
`
`the same customers, architects, and general contractors he worked with at Belimed. Therefore, it
`
`will not be possible for Bleecker to perform his new role without utilizing his copious knowledge
`
`of Belimed’s confidential information and without misappropriating Belimed’s goodwill.
`
`
`
`- 3 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 4 of 25
`
`6. Belimed brings this action to enjoin Bleecker’s violation of the Agreement by
`
`preventing him from working for Getinge.
`
`7. Belimed will be directly and immediately irreparably harmed if Bleecker is allowed
`
`to continue working for Getinge. Getinge will gain an unfair advantage in the industry that will
`
`have immediate impact on Belimed. Indeed, Getinge currently is involved as a competitor in at
`
`least two of Belimed’s ongoing business opportunities. For these reasons, Belimed seeks to
`
`enforce the Agreement and seeks preliminary and permanent injunctive relief, as well as
`
`damages, from this Court.
`
`PARTIES
`
`8. Plaintiff Belimed is a corporation duly organized and existing under the laws of
`
`Florida with its U.S. headquarters located in South Carolina at 8351 Palmetto Commerce
`
`Parkway, Suite 101, Ladson, South Carolina, 29456. Belimed has a registered agent in South
`
`Carolina.
`
`9. Defendant Jeffrey Bleecker is an individual residing at 9307 W. Country Club Trail,
`
`Peoria, Arizona, 85383. Bleecker was employed by Belimed as a Senior Planning and Design
`
`Manager (formerly known as a Project Planning Engineer) in the West region from May 4, 2015
`
`until December 2021.
`
`JURISDICTION AND VENUE
`
`10. This Court has personal jurisdiction over Bleecker because this action arises out of
`
`Bleecker’s specific contacts with the state of South Carolina. Bleecker was employed by
`
`Belimed, whose U.S. headquarters are in Ladson, South Carolina. Bleecker was recruited by
`
`Belimed employees based in South Carolina, interviewed for his position with Belimed in person
`
`in South Carolina, and regularly communicated with Belimed employees based in the South
`
`
`
`- 4 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 5 of 25
`
`Carolina headquarters, including two of his direct supervisors. Bleecker regularly submitted
`
`expense reports to the finance group located in the South Carolina headquarters for approval, and
`
`his paycheck issued from the South Carolina headquarters. In the course of nearly seven years
`
`working for Belimed, Bleecker traveled to South Carolina regularly for meetings, trainings, and
`
`other work activities. Bleecker also attended virtual trainings and meetings led by Belimed
`
`employees in South Carolina.
`
`11. As an additional South Carolina contact, Bleecker agreed in the Agreement that the
`
`Agreement would be governed by South Carolina law. Ex. A, ¶8. This action arises out of
`
`Bleecker’s breach of the Agreement.
`
`12. This Court has jurisdiction over the subject matter of this case pursuant to 28 U.S.C.
`
`§ 1332 because there is complete diversity between Plaintiff and Defendant, and Belimed has
`
`been and will continue to be injured in an amount exceeding $75,000, to be proved at trial.
`
`13. Venue in this Court is proper under 28 U.S.C. § 1391(b).
`
`FACTS
`
`Belimed’s Business
`
`14. Belimed is a leading supplier of medical and surgical instrument sterilization,
`
`disinfection, and cleaning products and services to health systems, hospitals, ambulatory surgical
`
`centers (ASCs), other facilities that have functioning operating rooms, and group purchasing
`
`organizations that serve these entities throughout the United States and worldwide. Belimed
`
`provides a complete spectrum of sterile workflow solutions including planning and design,
`
`market-leading equipment, consumables, servicing, data connectivity, education and training.
`
`Sterile workflows are the intentional path created between operating rooms and sterile areas to
`
`ensure that operating room instruments remain sterile.
`
`
`
`- 5 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 6 of 25
`
`15. Belimed uses proprietary tools and calculators that it developed to precisely identify
`
`the design and sterilization equipment they need for their specific spaces and to provide
`
`comprehensive advice.
`
`16. Belimed has expended substantial time, money, and effort developing these
`
`proprietary customer tools, as well as its customer services, professional reputation, relationships
`
`with customers and sales network throughout the United States and worldwide. Belimed has
`
`developed highly valuable confidential and proprietary business information, including its
`
`current and prospective customer lists, pricing data, purchasing histories, market intelligence and
`
`strategies, product research and development information, and overall industry and product
`
`expertise.
`
`17. Belimed’s confidential and proprietary information is not publicly known or
`
`reasonably ascertainable by competitors or other third parties. Belimed has taken reasonable
`
`measures to maintain the confidentiality and secrecy of all such information, including by
`
`requiring employees to sign non-competes and non-disclosures, protecting computer systems by
`
`unique password, labeling certain documents as confidential, restricting certain folders and
`
`documents to specific employees, and requiring every employee to sign some version of a
`
`confidentiality agreement. Belimed provides employees with access to trade secrets and
`
`confidential information only when necessary to perform their job duties and function.
`
`Belimed and Getinge are Direct Competitors
`
`18. Belimed is in a specialized and highly competitive industry. Getinge is one of
`
`Belimed’s primary competitors in the United States and beyond, where they both compete.
`
`Belimed is presently competing to win at least two contracts on which Getinge is the incumbent
`
`supplier.
`
`
`
`- 6 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 7 of 25
`
`19. Both Getinge and Belimed are ultimately focused on serving the needs of surgical
`
`teams and surgery departments with functioning operating rooms. They compete in all
`
`geographic regions.
`
`20. The product offerings of both Getinge and Belimed support operating room function
`
`and result in the companies targeting the same customers, including hospitals, ambulatory
`
`surgical centers (ASCs), other facilities that have functioning operating rooms, and group
`
`purchasing organizations that serve these sectors.
`
`21. With respect to sterilization equipment, cleaning equipment, and disinfectors, Getinge
`
`and Belimed are in direct competition in the planning and design of installations, as well as in the
`
`manufacturing, installing, and servicing of the equipment.
`
`22. The competition between Getinge and Belimed is not limited to sterilization and
`
`disinfecting equipment. Getinge also provides planning, design, manufacture, installation, and
`
`servicing for additional equipment used to support surgical teams beyond the scope of products
`
`that Belimed provides. When Getinge competes against Belimed in the sale of sterilization and
`
`disinfection equipment, Getinge attempts to leverage its ability to plan, design, manufacture,
`
`install, and service operating room equipment (such as operating room tables and operating room
`
`lighting) as a competitive advantage.
`
`23. A primary focus of Belimed’s internal strategy discussions is identifying ways to
`
`distinguish its products and services from those of competitors like Getinge in order to overcome
`
`competitors’ broader offerings.
`
`24. Getinge and Belimed also compete to build relationships with the same individuals.
`
`In general, the same individuals at a particular health care facility influence and make purchasing
`
`decisions for all types of equipment that directly support operating room function. The same
`
`
`
`- 7 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 8 of 25
`
`individuals are responsible for making purchasing decisions for the operating room tables and
`
`operating room lighting as for the sterilization and disinfection equipment that is integrally
`
`related to successful operating room function.
`
`25. Belimed expends significant resources building goodwill with these individuals in
`
`order to effectively compete with Getinge.
`
`Bleecker’s Role at Belimed and Access to Confidential Information
`
`26. Bleecker was employed by Belimed for almost seven years, from May 2015 to
`
`December 2021.
`
`27. As a result of his employment with Belimed and the position of trust he held with
`
`Belimed, Bleecker was given access to trade secrets and confidential information across multiple
`
`key areas of Belimed’s business. He received extensive and detailed education and in-depth
`
`working knowledge of Belimed’s comprehensive suite of proprietary tools for planning and
`
`designing customized installations of equipment to meet the clinical needs and spatial
`
`requirements of each individual customer. These proprietary tools, taken individually and in
`
`combination, represent one of Belimed’s leading strategic advantages over its competitors and
`
`provide a critically important differentiator in the marketplace.
`
`28. Bleecker was also given direct access to Belimed’s library of installed equipment
`
`information, which includes blueprints and drawings of customers’ specific facilities which
`
`Belimed used to tailor its offers to customers’ needs. Bleecker also created and regularly worked
`
`with installed equipment information as it was part of every sales effort. Information contained
`
`in these blueprints is directly valuable to a direct competitor like Getinge as it would allow
`
`Getinge to rely on the work done by Belimed to tailor offers to specific customers.
`
`
`
`- 8 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 9 of 25
`
`29. Belimed also disclosed to Bleecker its confidential research and development pipeline
`
`for ongoing equipment initiatives being executed to enhance Belimed’s competitive advantage.
`
`30. Because Bleecker was in a customer facing role, he also had detailed knowledge of
`
`confidential information regarding Belimed’s service coverage shortages and equipment
`
`challenges. Bleecker could use his knowledge of any regions where Belimed’s service was not
`
`as strong to help competitors, like Getinge, sway customers in that region to leave Belimed.
`
`31. Bleecker also was given access to Belimed’s confidential pricing structuring,
`
`Belimed’s confidential sales strategy, and Belimed’s proprietary design software used to build
`
`customer confidence and encourage customer purchase orders.
`
`32. Bleecker was provided and trained in Belimed’s strategy and tactics used to
`
`outperform Getinge and one other named competitor, Steris. He was given direct access to
`
`Belimed’s highly confidential sales pipeline and related prioritization, key contact information,
`
`strategy, project timelines, and additional project sensitive information.
`
`33. During his employment, Bleecker also learned about Belimed’s confidential 2022
`
`pipeline and 2023-2026 pipeline projections and was privy to Belimed’s confidential strategy
`
`and work with key vendor partners that provide another Belimed competitive advantage.
`
`34. Because Bleecker served in a customer facing role, he was introduced to, and, as part
`
`of his Belimed work, developed relationships with key decision-makers at individual health
`
`systems as well as architects, equipment planners, and project managers. Given that Getinge and
`
`Belimed compete for the business of the same health care providers, Bleecker will be working
`
`with the same decision-makers at individual health systems and the same architects and project
`
`managers in his new role at Getinge.
`
`
`
`- 9 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 10 of 25
`
`35. As part of his work at Belimed, Bleecker was given access to confidential information
`
`regarding design proposals made to customers and contract status and timing. Specifically,
`
`Bleecker was closely involved with two large opportunities that Belimed is currently competing
`
`to win where Getinge is the incumbent.
`
`36. By virtue of his frequent interaction both with customers and with Belimed’s product
`
`development team, Bleecker was instrumental in identifying and evaluating functionality
`
`concerns for new products and proposed product changes, and regularly provided feedback to the
`
`product development team. Polston Decl. ¶13. Bleecker also was privy to confidential
`
`information concerning relative strengths and perceived shortcomings in Belimed’s product and
`
`made proposals to address those relative strengths and shortcomings. Id. Because of his
`
`involvement in product development efforts, Bleecker was familiar with technical aspects of
`
`Belimed’s products that were critical to Belimed’s efforts to differentiate its products from those
`
`of its competitors, including Getinge. Id.
`
`37. Bleecker regularly participated in, and was privy to confidential information about,
`
`Belimed’s sales efforts. Bleecker regularly spoke with and made proposals to existing and
`
`potential Belimed customers, provided customers with Belimed’s comprehensive proprietary
`
`suite of tools for planning and designing customized installations of equipment to meet their
`
`needs, and had access to Belimed’s current and prospective customer lists.
`
`38. Belimed paid Bleecker to be involved in developing Belimed’s goodwill with its
`
`customers and prospective customers, as he had an ongoing role in the sales process and in
`
`interacting with customers.
`
`
`
`
`
`- 10 -
`
`
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 11 of 25
`
`Bleecker’s Agreement with Belimed
`
`39. To safeguard Belimed’s trade secrets, confidential information and goodwill,
`
`Bleecker entered into the Agreement with Belimed as a condition of his initial employment.
`
`Protection of the trade secrets, confidential information, and goodwill is crucial to Belimed’s
`
`success.
`
`40. Paragraph 1(a) of the Agreement provides that, that during his employment, Bleecker
`
`would be “in a position of confidence and trust with respect to the business, operations, and
`
`customers” of Belimed and would have access to trade secrets and confidential information. Ex.
`
`A, ¶1. “Trade Secrets” are defined in the Agreement as:
`
`•
`
`•
`
`•
`
`information, including, but not limited to, a formula, pattern, compilation,
`program, device, method, technique, or process that: (i) derives independent
`economic value, actual or potential, from not being generally known to, and not
`being readily ascertainable by proper means by, the public or any other person
`who can obtain economic value from its disclosure or use, and (ii) is the subject of
`efforts that are reasonable under the circumstances to maintain its secrecy.
`
`Employee acknowledges that Employer’s Trade Secrets include, but are not
`limited to, the following information which meets the above definition:
`information regarding Employer’s product designs, marketing, and sales
`•
`objectives and strategies;
`information regarding Employer’s customers and prospective customers
`and customer lists; information regarding existing customer preferences,
`habits and needs, including details of past, pending, and contemplated
`transactions, and customer proposals;
`information regarding Employer’s pricing, including, but not limited to,
`price lists, pricing policies, and pricing strategies;
`information regarding Employer’s sales, sales data, training materials, and
`marketing and distribution approaches;
`information developed by Employer regarding its competitors and
`competitive position in the industry;
`information regarding Employer’s systems, strategies, designs, processes,
`procedures, market data, know-how, compilations of technical and non-
`technical data, advertising, and promotional plans and strategies;
`information regarding Employer’s finances, financial structure, financial
`condition, assets and liabilities, and projections relating to the business;
`
`•
`
`•
`
`•
`
`
`
`- 11 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 12 of 25
`
`•
`
`•
`
`information regarding Employer’s operations, business plans, business
`opportunities, project concepts, designs, and drawings, and project
`research and analyses;
`information regarding Employer’s software designs; and Information
`regarding trials, tests, and products developed in Employer’s effort to
`satisfy the needs of its customers and potential customers, and information
`contained in personnel files, work papers, financial statements and tax
`returns.
`
`
`Ex. A, ¶1(b).
`
`41. Confidential information is defined as “any information which does not rise to the
`
`level of a Trade Secret, but which Employer uses in its business and treats as and considers to be
`
`confidential or proprietary, and which is not generally known in the industry. Ex. A, ¶1(c).
`
`42. By signing the Agreement, Bleecker expressly agreed to use his “best efforts and
`
`utmost diligence” to protect Belimed’s trade secrets and confidential information and not to
`
`disclose such information to another person or entity. Ex. A, ¶1.
`
`43. Paragraph 3 of the Agreement provides that during Bleecker’s employment and for
`
`one year after, Bleecker would not “directly or indirectly, obtain ownership in, work, advise,
`
`consult, or volunteer for or with” two specifically-identified direct competitors, Getinge and
`
`Steris Corporation. Ex. A, ¶3.
`
`44. The Agreement further provides that the one-year non-compete period would be
`
`extended by the length of any violative activity by Bleecker. Ex. A, ¶5.
`
`45. Bleecker expressly agreed that the restrictive covenants contained in the Agreement
`
`would not prevent him from earning a living, Ex. A, ¶4, and that the limited restrictions in the
`
`Agreement were “reasonable and necessary to protect [Belimed’s] legitimate business interests.”
`
`Ex. A, ¶1(e).
`
`46. Bleecker also agreed that any breach or threatened breach of the Agreement would
`
`cause Belimed irreparable harm and that Belimed would be entitled to obtain temporary and
`
`
`
`- 12 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 13 of 25
`
`permanent injunctive relief against any breach or threatened breach of the Agreement, in addition
`
`to all other rights and remedies available to Belimed under South Carolina law. Ex. A, ¶¶5, 8.
`
`Bleecker agreed that he would pay Belimed’s attorney’s fees should it prevail in any litigation to
`
`prevent breaches by Bleecker of the Agreement. Ex. A ¶8.
`
`47. Bleecker also agreed that “[a]ll matters affecting the Agreement are to be governed
`
`by, interpreted, and construed in accordance with the laws of the State of South Carolina.” Ex.
`
`A, ¶8.
`
`Bleecker’s Breach of the Agreement
`
`48. On or about December 17, 2021, Bleecker notified his supervisor, Ross Polston, that
`
`he was resigning from Belimed, effective December 31, 2021. Polston Decl. ¶21. Bleecker
`
`represented to Belimed at that time that he was returning to the role of entrepreneur and would
`
`be building his general contractor business.
`
`49. According to his LinkedIn resume and the Arizona Corporation Commission’s
`
`website, Bleecker is the principal of an entity named Old Glory Development, an active entity in
`
`good standing, incorporated in 2007 in Arizona. Upon information and belief, this is Bleecker’s
`
`general contractor business.
`
`50. Prior to his departure, Bleecker sent copies of documents related to his employment
`
`with Belimed to his personal email address. On November 17, 2021, and again on December 7,
`
`2021, Bleecker sent a copy of his employment documents, including the Agreement, to his
`
`personal email.
`
`51. On December 6, 2021, Bleecker sent a screenshot of a proprietary and confidential
`
`Belimed internal presentation on to his personal email. The presentation contained proprietary
`
`information and trade secrets about a new web-based application that Belimed was developing.
`
`
`
`- 13 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 14 of 25
`
`52. The internal presentation was Belimed’s property. Ex. A ¶1(i). Bleecker should not
`
`have taken it and should have returned it prior to his departure, Ex. A ¶1(h), but he did not.
`
`53. The Company is still investigating if other Belimed materials were taken by Bleecker.
`
`54. Bleecker’s last day of employment with Belimed was December 31, 2021.
`
`55. In February 2022, Belimed discovered that Bleecker had shared on the professional
`
`networking site LinkedIn that he is currently employed by Belimed’s direct competitor Getinge
`
`as a “Healthcare Planning & Design Manager.” Polston Decl. ¶23, Ex. 1.
`
`56. Bleecker was required to share his Agreement with Getinge. Ex. A, ¶6.
`
`57. Bleecker’s employment with Getinge violates the non-compete provision of the
`
`Agreement. Ex. A, ¶3.
`
`58. Bleecker’s job title at Belimed was virtually identical to his current job title at
`
`Getinge. At Belimed, Bleecker served as a Senior Planning and Design Manager. Bleecker has
`
`shared on LinkedIn his title is “Healthcare Planning & Design Manager.” Polston Decl. ¶¶23–
`
`25, Ex. 1.
`
`59. Upon information and belief, Bleecker’s full job title actually specifies that he has
`
`been assigned to the Surgical Workflow division at Getinge. Polston Decl. ¶ 25.
`
`60. In addition to his title, Bleecker included a reference in his LinkedIn posting to
`
`“#SterileWorkflows.” Polston Decl., Ex. 1. Sterile Workflows refers to the intentional and
`
`deliberate path created between operating rooms and sterile areas to ensure that operating room
`
`instruments remain sterile. Bleecker specifically worked on designing sterile processing
`
`departments, a critical component of sterile workflows, while he was employed by Belimed.
`
`Polston Decl. ¶19. In addition to this reference, Brent Begin, Vice President of Sales at Getinge,
`
`
`
`- 14 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 15 of 25
`
`commented on Mr. Bleecker’s posting, writing “We’re excited to have you join us in our journey
`
`at Surgical Workflows.” Polston Decl., Ex. 1.
`
`61. The Surgical Workflows division at Getinge supports the function of operating rooms
`
`and includes the staff that work with sterilization equipment, cleaning equipment, and
`
`disinfectors that compete directly with Belimed’s products. The Surgical Workflow division at
`
`Getinge also includes the planning, design, manufacture, installation, and servicing of equipment
`
`used in operating rooms, including but not limited to operating room tables and operating room
`
`lights. As described in Getinge’s annual report for 2021, “Surgical Workflows offers products
`
`and solutions to serve as an end-to-end partner for optimizing the quality, safety, and capacity
`
`usage of the sterile supply departments and operating rooms.” See Getinge 2021 Year-end
`
`Report,
`
`available
`
`at
`
`https://mediahubprodstorage.blob.core.windows.net/mediahub-
`
`assets/531/84531/original/Year_End_Report_January_December_2021.pdf
`
`(“Getinge
`
`2021
`
`Annual Report”) at p. 7.
`
`62. The competition between Belimed and the Surgical Workflow division at Getinge is
`
`real and involves high stakes. The same page of the Getinge 2021 Annual Report references a
`
`group purchasing organization contract that Getinge’s Surgical Workflow division won from
`
`Belimed in 2021. Id.
`
`63. In addition, Bleecker’s own description of his new position on LinkedIn reflects that
`
`he holds a very similar position at Getinge to the one he held at Belimed, including that he would
`
`be “back in the Operating Room environment working with Architects, Equipment Planners,
`
`Engineers and General Contractors” as he had at Belimed. Polston Decl., Ex. 1.
`
`64. Bleecker’s activities at Getinge will necessarily involve the sterilization equipment
`
`that both Getinge and Belimed manufacture, install, and service.
`
`
`
`- 15 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 16 of 25
`
`65. The planning and design of operating rooms is not limited to the selection and
`
`positioning of operating room tables and operating room lights. The sterile core of the operating
`
`room includes the areas that are immediately integrated within the operating room, including the
`
`areas for sinks where the surgical team members scrub their hands and arms, the location of
`
`equipment to warm blankets, storage cabinets, and closets.
`
`66. The sterilization processing department is typically located close to the operating
`
`rooms and is where a concentration of sterilization equipment and disinfecting equipment is
`
`typically placed to serve the needs of the operating rooms.
`
`67. In some instances, sterilization equipment is installed within the operating room or
`
`the connected core sterile area, permitting the operating room team to flash sterilize an
`
`instrument if needed quickly. During his employment at Belimed, Bleecker worked on the
`
`design of sterilization equipment installations within a number of operating rooms and connected
`
`core sterile areas.
`
`68. Because sterilization equipment and operating room design are integrally connected,
`
`it is impossible that Bleecker’s key knowledge gained at Belimed would not cover areas in which
`
`Getinge competes with Belimed.
`
`69. Bleecker’s role at Getinge will rely on the proprietary information and approach to
`
`planning and design that Bleecker learned while at Belimed using Belimed’s resources.
`
`70. The proprietary planning and design techniques taught to Bleecker at Belimed are all
`
`applicable to the equipment in the operating room setting. This includes a proprietary approach
`
`to interviewing hospital officials regarding the volume and characteristics of the surgical
`
`procedures performed at the institution and translating this input into specific, actionable
`
`purchase and installation recommendations.
`
`
`
`- 16 -
`
`

`

`2:22-cv-00891-DCN Date Filed 03/17/22 Entry Number 1 Page 17 of 25
`
`71. It is not possible that Bleecker can perform his job at Getinge without utilizing these
`
`techniques and misappropriating Belimed’s confidential information in violation of the non-
`
`disclosure provision of the Agreement.
`
`72. Bleecker’s employment at Getinge also focuses on serving the same customers that
`
`Getinge and Belimed directly compete to serve.
`
`73. Bleecker’s own words in his LinkedIn posting that he will “be back in the Operating
`
`Room environment” highlight that his employment at Getinge is a retur

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket